# Oral Cyanocobalamin (Eligen B12) Bioavailability Study

> **NCT01311739** · NA · COMPLETED · sponsor: **Emisphere Technologies, Inc.** · enrollment: 20 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Cyanocobalamin

## Key facts

- **NCT ID:** NCT01311739
- **Lead sponsor:** Emisphere Technologies, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** —
- **Final completion:** 2008-06
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2011-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01311739

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01311739, "Oral Cyanocobalamin (Eligen B12) Bioavailability Study". Retrieved via AI Analytics 2026-09-10 from https://api.ai-analytics.org/clinical/NCT01311739. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*